Posted by Michael Wonder on 08 Mar 2021
Viatris and Kindeva Drug Delivery announce FDA tentative approval of the first abbreviated new drug application generic version of Symbicort (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
8 March 2021 - Milestone reinforces Viatris' commitment to complex products and innovative solutions to help increase patient access
Viatris and Kindeva Drug Delivery announced that the U.S. FDA granted tentative approval of budesonide/formoterol fumarate dihydrate products, the first generic version of Symbicort based on an abbreviated new drug application.
